Cargando…

Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach

Long-term oxygen therapy (LTOT) has become standard care for the treatment of patients with chronic obstructive pulmonary disease (COPD) and other severe hypoxemic lung diseases. The use of new portable O(2) concentrators (POC) in LTOT is being expanded. However, the issue of oxygen titration is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Morillo, Daniel, Muñoz-Zara, Pilar, Lara-Doña, Alejandro, Leon-Jimenez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070269/
https://www.ncbi.nlm.nih.gov/pubmed/32093418
http://dx.doi.org/10.3390/s20041178
_version_ 1783505935887499264
author Sanchez-Morillo, Daniel
Muñoz-Zara, Pilar
Lara-Doña, Alejandro
Leon-Jimenez, Antonio
author_facet Sanchez-Morillo, Daniel
Muñoz-Zara, Pilar
Lara-Doña, Alejandro
Leon-Jimenez, Antonio
author_sort Sanchez-Morillo, Daniel
collection PubMed
description Long-term oxygen therapy (LTOT) has become standard care for the treatment of patients with chronic obstructive pulmonary disease (COPD) and other severe hypoxemic lung diseases. The use of new portable O(2) concentrators (POC) in LTOT is being expanded. However, the issue of oxygen titration is not always properly addressed, since POCs rely on proper use by patients. The robustness of algorithms and the limited reliability of current oximetry sensors are hindering the effectiveness of new approaches to closed-loop POCs based on the feedback of blood oxygen saturation. In this study, a novel intelligent portable oxygen concentrator (iPOC) is described. The presented iPOC is capable of adjusting the O(2) flow automatically by real-time classifying the intensity of a patient’s physical activity (PA). It was designed with a group of patients with COPD and stable chronic respiratory failure. The technical pilot test showed a weighted accuracy of 91.1% in updating the O(2) flow automatically according to medical prescriptions, and a general improvement in oxygenation compared to conventional POCs. In addition, the usability achieved was high, which indicated a significant degree of user satisfaction. This iPOC may have important benefits, including improved oxygenation, increased compliance with therapy recommendations, and the promotion of PA.
format Online
Article
Text
id pubmed-7070269
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70702692020-03-19 Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach Sanchez-Morillo, Daniel Muñoz-Zara, Pilar Lara-Doña, Alejandro Leon-Jimenez, Antonio Sensors (Basel) Article Long-term oxygen therapy (LTOT) has become standard care for the treatment of patients with chronic obstructive pulmonary disease (COPD) and other severe hypoxemic lung diseases. The use of new portable O(2) concentrators (POC) in LTOT is being expanded. However, the issue of oxygen titration is not always properly addressed, since POCs rely on proper use by patients. The robustness of algorithms and the limited reliability of current oximetry sensors are hindering the effectiveness of new approaches to closed-loop POCs based on the feedback of blood oxygen saturation. In this study, a novel intelligent portable oxygen concentrator (iPOC) is described. The presented iPOC is capable of adjusting the O(2) flow automatically by real-time classifying the intensity of a patient’s physical activity (PA). It was designed with a group of patients with COPD and stable chronic respiratory failure. The technical pilot test showed a weighted accuracy of 91.1% in updating the O(2) flow automatically according to medical prescriptions, and a general improvement in oxygenation compared to conventional POCs. In addition, the usability achieved was high, which indicated a significant degree of user satisfaction. This iPOC may have important benefits, including improved oxygenation, increased compliance with therapy recommendations, and the promotion of PA. MDPI 2020-02-20 /pmc/articles/PMC7070269/ /pubmed/32093418 http://dx.doi.org/10.3390/s20041178 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sanchez-Morillo, Daniel
Muñoz-Zara, Pilar
Lara-Doña, Alejandro
Leon-Jimenez, Antonio
Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach
title Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach
title_full Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach
title_fullStr Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach
title_full_unstemmed Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach
title_short Automated Home Oxygen Delivery for Patients with COPD and Respiratory Failure: A New Approach
title_sort automated home oxygen delivery for patients with copd and respiratory failure: a new approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070269/
https://www.ncbi.nlm.nih.gov/pubmed/32093418
http://dx.doi.org/10.3390/s20041178
work_keys_str_mv AT sanchezmorillodaniel automatedhomeoxygendeliveryforpatientswithcopdandrespiratoryfailureanewapproach
AT munozzarapilar automatedhomeoxygendeliveryforpatientswithcopdandrespiratoryfailureanewapproach
AT laradonaalejandro automatedhomeoxygendeliveryforpatientswithcopdandrespiratoryfailureanewapproach
AT leonjimenezantonio automatedhomeoxygendeliveryforpatientswithcopdandrespiratoryfailureanewapproach